AITRICS' VitalCare Achieves Vietnam Medical Device License

AITRICS, a medical AI company, recently secured a medical device license for its VitalCare solution in Vietnam. This advancement marks a significant milestone for the company as it looks to expand its presence in Southeast Asia and enhance its global footprint.

What is VitalCare?

VitalCare is AITRICS’ predictive AI solution designed to anticipate patient deterioration. It analyzes up to 19 types of electronic medical record (EMR) data to foresee potential adverse events in hospital settings. Here’s how it works:

• Acute Severe Events: Predicts events like death, ICU transfers, and cardiac arrests in general wards within 6 hours.
• Sepsis: Detects sepsis risk in general wards within 4 hours.
• Cardiac Arrest: Forecasts cardiac arrests occurring within 24 hours.
• Mortality in ICU: Gauges mortality risk in intensive care units within 6 hours.

Vietnam's Medical Device Market Prospects

Vietnam is aggressively investing in its medical sector, creating a flourishing market for medical devices. A few notable trends include:

• The market has grown at an average annual growth rate of 8.76% since 2016.
• Expected to reach a market size of $2.575 billion by 2025.
• Increased investment and healthcare budget boost market expansion.

AITRICS’ Global Expansion Goals

Kim Kwang-joon, CEO of AITRICS, states that the approval in Vietnam sets the stage for further expansion into Southeast Asia. The company is also eyeing broader global markets, with strategies to enhance its presence in:

1. United States: Focuses on penetrating the U.S. market post-FDA approval obtained in August.
2. Southeast Asia: Actively pursuing certifications in countries like Indonesia and Malaysia.
3. Europe: Plans to extend its reach to the European market.

Deployment of VitalCare

Currently, more than 60 hospitals in South Korea use the VitalCare solution. Its high adoption rate underscores its effectiveness and potential value in international healthcare settings.

Key Points on Expansion Efforts:

• Vietnam: Serves as a strategic entry point for Southeast Asian markets.
• Regulatory Approvals: Aims to win approvals across multiple countries to facilitate broader adoption.
• Market Strategy: Prioritizes markets with growing healthcare investments and supportive regulatory environments.

Conclusion

AITRICS is positioned strategically with its VitalCare solution to meet the rising demand for predictive healthcare technologies globally. With its successful entry into Vietnam, the company exemplifies how cutting-edge AI can transform healthcare by predicting critical medical events, thereby saving lives and optimizing care delivery.